| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 510.62K | $ 496.03K | $ 714.71K | $ 707.41K | $ 1.61M |
| Gross Profit | $ 433.35K | $ 363.70K | $ 466.39K | $ 486.52K | $ 795.53K |
| Operating Income | $ 81.27K | $ -392.69K | $ -274.29K | $ -343.45K | $ -154.45K |
| EBITDA | $ 81.27K | $ -392.69K | $ -274.29K | $ -343.45K | $ 161.89K |
| Net Income | $ -532.49K | $ -930.65K | $ -722.81K | $ -784.91K | $ -289.82K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.51K | $ 7.87K | $ 4.69K | $ 45.04K | $ 925.00 |
| Total Assets | $ 142.36K | $ 43.33K | $ 144.39K | $ 250.19K | $ 83.89K |
| Total Debt | $ 16.29M | $ 15.53M | $ 14.83M | $ 14.09M | $ 13.34M |
| Net Debt | $ 16.29M | $ 15.52M | $ 14.83M | $ 14.04M | $ 13.34M |
| Total Liabilities | $ 18.08M | $ 17.45M | $ 16.62M | $ 16.01M | $ 15.20M |
| Stockholders' Equity | $ -17.94M | $ -17.41M | $ -16.48M | $ -15.76M | $ -15.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -151.41K | $ -164.15K | $ -335.99K | $ -478.60K | $ -320.30K |
| Operating Cash Flow | $ -151.41K | $ -164.15K | $ -335.99K | $ -478.60K | $ -320.30K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 147.05K | $ 167.34K | $ 295.64K | $ 522.71K | $ 211.61K |
BioElectronics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.